Universal Transport Medium (UTM) ® is an FDA-cleared collecti...
Eli Lilly and Company has announced the opening of the LIBRETTO-531 cl...
The Janssen Pharmaceutical Companies of Johnson & Johnson announce...
The U.S. Food and Drug Administration has approved two applications fo...
AstraZeneca and MSD have announced that Lynparza (olaparib) ...
Pregnant women exposed to persistent organic pollutants, or POPs, had ...
Medigate, a dedicated medical device security and asset management sol...
GenScript, the world's leading gene synthesis provider has announced t...
The Janssen Pharmaceutical Companies of Johnson & Johnson announce...
Theravance Biopharma Ireland Limited, a subsidiary of Theravance Bioph...
The U.S. Food and Drug Administration has approved two applications fo...
Roche and Sarepta Therapeutics, have announced the signing of a licens...
Mumbai, 18 December 2019: CPhI & P-MEC India 2019 &ndash...
National Comprehensive Cancer Network® (NCCN®) published ...
Roche has announced that the European Commission has approved Kadcyla&...
Eli Lilly and Company has announced a global commercialization agreeme...
Roche and Spark Therapeutics, Inc. have announced the completion of th...
Pfizer Inc. and Astellas Pharma Inc. have announced today the U.S. Foo...
